APO Research
Talk to an analyst

APO RESEARCH · REPORT

Meningococcal Group B Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Meningococcal Group B Vaccine Market Analysis and Forecast 2026-2032

22 December 2025190 pages

Choose your research edition.

Industry ResearchMeningococcal Group B Vaccine Industry Research Report 2026112 pages · $2,950 USDIndustry Growth & TrendsGlobal Meningococcal Group B Vaccine Industry Growth and Trends Forecast to 203279 pages · $3,450 USDMarket StructureGlobal Meningococcal Group B Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032175 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Meningococcal Group B Vaccine Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Meningococcal Group B Vaccine Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Meningococcal Group B Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Meningococcal Group B Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Meningococcal Group B Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Meningococcal Group B Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Meningococcal Group B Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Meningococcal Group B Vaccine include GSK and Pfizer etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Meningococcal Group B Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Meningococcal Group B Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Meningococcal Group B Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Meningococcal Group B Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Meningococcal Group B Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Meningococcal Group B Vaccine sales, projected growth trends, production technology, application and end-user industry.

Meningococcal Group B Vaccine Segment by Company

GSK

Pfizer

Meningococcal Group B Vaccine Segment by Type

Bexsero

Trumenba

Other

Meningococcal Group B Vaccine Segment by Application

Public

Private

Meningococcal Group B Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Meningococcal Group B Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Meningococcal Group B Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Meningococcal Group B Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Meningococcal Group B Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Meningococcal Group B Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Meningococcal Group B Vaccine sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Meningococcal Group B Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Bexsero Major Manufacturers Table 3. Trumenba Major Manufacturers Table 4. Other Major Manufacturers Table 5. Global Meningococcal Group B Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Public Major Manufacturers Table 7. Private Major Manufacturers Table 8. Meningococcal Group B Vaccine Industry Trends Table 9. Meningococcal Group B Vaccine Industry Drivers Table 10. Meningococcal Group B Vaccine Industry Opportunities and Challenges Table 11. Meningococcal Group B Vaccine Industry Restraints Table 12. Global Meningococcal Group B Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Meningococcal Group B Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Meningococcal Group B Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Meningococcal Group B Vaccine Revenue Market Share by Region (2021-2026) Table 16. Global Meningococcal Group B Vaccine Revenue Market Share by Region (2027-2032) Table 17. Global Meningococcal Group B Vaccine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 18. Global Meningococcal Group B Vaccine Sales by Region (2021-2026) & (k units) Table 19. Global Meningococcal Group B Vaccine Sales by Region (2027-2032) & (k units) Table 20. Global Meningococcal Group B Vaccine Sales Market Share by Region (2021-2026) Table 21. Global Meningococcal Group B Vaccine Sales Market Share by Region (2027-2032) Table 22. Global Meningococcal Group B Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Meningococcal Group B Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Meningococcal Group B Vaccine Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Meningococcal Group B Vaccine Sales Market Share by Manufacturers (2021-2026) Table 26. Global Meningococcal Group B Vaccine Sales Price (US$/unit) of Manufacturers (2021-2026) Table 27. Global Meningococcal Group B Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Meningococcal Group B Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Meningococcal Group B Vaccine Manufacturers, Product Type & Application Table 30. Global Meningococcal Group B Vaccine Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Meningococcal Group B Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Meningococcal Group B Vaccine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Meningococcal Group B Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Meningococcal Group B Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Meningococcal Group B Vaccine Revenue Market Share by Type (2021-2026) Table 37. Global Meningococcal Group B Vaccine Revenue Market Share by Type (2027-2032) Table 38. Global Meningococcal Group B Vaccine Sales by Type 2021 VS 2025 VS 2032 (k units) Table 39. Global Meningococcal Group B Vaccine Sales by Type (2021-2026) & (k units) Table 40. Global Meningococcal Group B Vaccine Sales by Type (2027-2032) & (k units) Table 41. Global Meningococcal Group B Vaccine Sales Market Share by Type (2021-2026) Table 42. Global Meningococcal Group B Vaccine Sales Market Share by Type (2027-2032) Table 43. Global Meningococcal Group B Vaccine Price by Type (2021-2026) & (US$/unit) Table 44. Global Meningococcal Group B Vaccine Price by Type (2027-2032) & (US$/unit) Table 45. Global Meningococcal Group B Vaccine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Meningococcal Group B Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Meningococcal Group B Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Meningococcal Group B Vaccine Revenue Market Share by Application (2021-2026) Table 49. Global Meningococcal Group B Vaccine Revenue Market Share by Application (2027-2032) Table 50. Global Meningococcal Group B Vaccine Sales by Application 2021 VS 2025 VS 2032 (k units) Table 51. Global Meningococcal Group B Vaccine Sales by Application (2021-2026) & (k units) Table 52. Global Meningococcal Group B Vaccine Sales by Application (2027-2032) & (k units) Table 53. Global Meningococcal Group B Vaccine Sales Market Share by Application (2021-2026) Table 54. Global Meningococcal Group B Vaccine Sales Market Share by Application (2027-2032) Table 55. Global Meningococcal Group B Vaccine Price by Application (2021-2026) & (US$/unit) Table 56. Global Meningococcal Group B Vaccine Price by Application (2027-2032) & (US$/unit) Table 57. GSK Company Information Table 58. GSK Business Overview Table 59. GSK Meningococcal Group B Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 60. GSK Meningococcal Group B Vaccine Product Portfolio Table 61. GSK Recent Development Table 62. Pfizer Company Information Table 63. Pfizer Business Overview Table 64. Pfizer Meningococcal Group B Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 65. Pfizer Meningococcal Group B Vaccine Product Portfolio Table 66. Pfizer Recent Development Table 67. North America Meningococcal Group B Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 68. North America Meningococcal Group B Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 69. North America Meningococcal Group B Vaccine Sales by Type (2021-2026) & (k units) Table 70. North America Meningococcal Group B Vaccine Sales by Type (2027-2032) & (k units) Table 71. North America Meningococcal Group B Vaccine Sales Price by Type (2021-2026) & (US$/unit) Table 72. North America Meningococcal Group B Vaccine Sales Price by Type (2027-2032) & (US$/unit) Table 73. North America Meningococcal Group B Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 74. North America Meningococcal Group B Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 75. North America Meningococcal Group B Vaccine Sales by Application (2021-2026) & (k units) Table 76. North America Meningococcal Group B Vaccine Sales by Application (2027-2032) & (k units) Table 77. North America Meningococcal Group B Vaccine Sales Price by Application (2021-2026) & (US$/unit) Table 78. North America Meningococcal Group B Vaccine Sales Price by Application (2027-2032) & (US$/unit) Table 79. North America Meningococcal Group B Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 80. North America Meningococcal Group B Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 81. North America Meningococcal Group B Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 82. North America Meningococcal Group B Vaccine Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 83. North America Meningococcal Group B Vaccine Sales by Country (2021-2026) & (k units) Table 84. North America Meningococcal Group B Vaccine Sales by Country (2027-2032) & (k units) Table 85. North America Meningococcal Group B Vaccine Sales Price by Country (2021-2026) & (US$/unit) Table 86. North America Meningococcal Group B Vaccine Sales Price by Country (2027-2032) & (US$/unit) Table 87. United States Meningococcal Group B Vaccine Revenue (2021-2032) & (US$ Million) Table 88. Canada Meningococcal Group B Vaccine Revenue (2021-2032) & (US$ Million) Table 89. Mexico Meningococcal Group B Vaccine Revenue (2021-2032) & (US$ Million) Table 90. Europe Meningococcal Group B Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 91. Europe Meningococcal Group B Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 92. Europe Meningococcal Group B Vaccine Sales by Type (2021-2026) & (k units) Table 93. Europe Meningococcal Group B Vaccine Sales by Type (2027-2032) & (k units) Table 94. Europe Meningococcal Group B Vaccine Sales Price by Type (2021-2026) & (US$/unit) Table 95. Europe Meningococcal Group B Vaccine Sales Price by Type (2027-2032) & (US$/unit) Table 96. Europe Meningococcal Group B Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 97. Europe Meningococcal Group B Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 98. Europe Meningococcal Group B Vaccine Sales by Application (2021-2026) & (k units) Table 99. Europe Meningococcal Group B Vaccine Sales by Application (2027-2032) & (k units) Table 100. Europe Meningococcal Group B Vaccine Sales Price by Application (2021-2026) & (US$/unit) Table 101. Europe Meningococcal Group B Vaccine Sales Price by Application (2027-2032) & (US$/unit) Table 102. Europe Meningococcal Group B Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 103. Europe Meningococcal Group B Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 104. Europe Meningococcal Group B Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 105. Europe Meningococcal Group B Vaccine Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 106. Europe Meningococcal Group B Vaccine Sales by Country (2021-2026) & (k units) Table 107. Europe Meningococcal Group B Vaccine Sales by Country (2027-2032) & (k units) Table 108. Europe Meningococcal Group B Vaccine Sales Price by Country (2021-2026) & (US$/unit) Table 109. Europe Meningococcal Group B Vaccine Sales Price by Country (2027-2032) & (US$/unit) Table 110. Germany Meningococcal Group B Vaccine Revenue (2021-2032) & (US$ Million) Table 111. France Meningococcal Group B Vaccine Revenue (2021-2032) & (US$ Million) Table 112. U.K. Meningococcal Group B Vaccine Revenue (2021-2032) & (US$ Million) Table 113. Italy Meningococcal Group B Vaccine Revenue (2021-2032) & (US$ Million) Table 114. Russia Meningococcal Group B Vaccine Revenue (2021-2032) & (US$ Million) Table 115. Spain Meningococcal Group B Vaccine Revenue (2021-2032) & (US$ Million) Table 116. Netherlands Meningococcal Group B Vaccine Revenue (2021-2032) & (US$ Million) Table 117. Switzerland Meningococcal Group B Vaccine Revenue (2021-2032) & (US$ Million) Table 118. Sweden Meningococcal Group B Vaccine Revenue (2021-2032) & (US$ Million) Table 119. Poland Meningococcal Group B Vaccine Revenue (2021-2032) & (US$ Million) Table 120. China Meningococcal Group B Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 121. China Meningococcal Group B Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 122. China Meningococcal Group B Vaccine Sales by Type (2021-2026) & (k units) Table 123. China Meningococcal Group B Vaccine Sales by Type (2027-2032) & (k units) Table 124. China Meningococcal Group B Vaccine Sales Price by Type (2021-2026) & (US$/unit) Table 125. China Meningococcal Group B Vaccine Sales Price by Type (2027-2032) & (US$/unit) Table 126. China Meningococcal Group B Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 127. China Meningococcal Group B Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 128. China Meningococcal Group B Vaccine Sales by Application (2021-2026) & (k units) Table 129. China Meningococcal Group B Vaccine Sales by Application (2027-2032) & (k units) Table 130. China Meningococcal Group B Vaccine Sales Price by Application (2021-2026) & (US$/unit) Table 131. China Meningococcal Group B Vaccine Sales Price by Application (2027-2032) & (US$/unit) Table 132. Asia Meningococcal Group B Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 133. Asia Meningococcal Group B Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 134. Asia Meningococcal Group B Vaccine Sales by Type (2021-2026) & (k units) Table 135. Asia Meningococcal Group B Vaccine Sales by Type (2027-2032) & (k units) Table 136. Asia Meningococcal Group B Vaccine Sales Price by Type (2021-2026) & (US$/unit) Table 137. Asia Meningococcal Group B Vaccine Sales Price by Type (2027-2032) & (US$/unit) Table 138. Asia Meningococcal Group B Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 139. Asia Meningococcal Group B Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 140. Asia Meningococcal Group B Vaccine Sales by Application (2021-2026) & (k units) Table 141. Asia Meningococcal Group B Vaccine Sales by Application (2027-2032) & (k units) Table 142. Asia Meningococcal Group B Vaccine Sales Price by Application (2021-2026) & (US$/unit) Table 143. Asia Meningococcal Group B Vaccine Sales Price by Application (2027-2032) & (US$/unit) Table 144. Asia Meningococcal Group B Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 145. Asia Meningococcal Group B Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 146. Asia Meningococcal Group B Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 147. Asia Meningococcal Group B Vaccine Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 148. Asia Meningococcal Group B Vaccine Sales by Country (2021-2026) & (k units) Table 149. Asia Meningococcal Group B Vaccine Sales by Country (2027-2032) & (k units) Table 150. Asia Meningococcal Group B Vaccine Sales Price by Country (2021-2026) & (US$/unit) Table 151. Asia Meningococcal Group B Vaccine Sales Price by Country (2027-2032) & (US$/unit) Table 152. Japan Meningococcal Group B Vaccine Revenue (2021-2032) & (US$ Million) Table 153. South Korea Meningococcal Group B Vaccine Revenue (2021-2032) & (US$ Million) Table 154. India Meningococcal Group B Vaccine Revenue (2021-2032) & (US$ Million) Table 155. Australia Meningococcal Group B Vaccine Revenue (2021-2032) & (US$ Million) Table 156. Taiwan Meningococcal Group B Vaccine Revenue (2021-2032) & (US$ Million) Table 157. Southeast Asia Meningococcal Group B Vaccine Revenue (2021-2032) & (US$ Million) Table 158. SAMEA Meningococcal Group B Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 159. SAMEA Meningococcal Group B Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 160. SAMEA Meningococcal Group B Vaccine Sales by Type (2021-2026) & (k units) Table 161. SAMEA Meningococcal Group B Vaccine Sales by Type (2027-2032) & (k units) Table 162. SAMEA Meningococcal Group B Vaccine Sales Price by Type (2021-2026) & (US$/unit) Table 163. SAMEA Meningococcal Group B Vaccine Sales Price by Type (2027-2032) & (US$/unit) Table 164. SAMEA Meningococcal Group B Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 165. SAMEA Meningococcal Group B Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 166. SAMEA Meningococcal Group B Vaccine Sales by Application (2021-2026) & (k units) Table 167. SAMEA Meningococcal Group B Vaccine Sales by Application (2027-2032) & (k units) Table 168. SAMEA Meningococcal Group B Vaccine Sales Price by Application (2021-2026) & (US$/unit) Table 169. SAMEA Meningococcal Group B Vaccine Sales Price by Application (2027-2032) & (US$/unit) Table 170. SAMEA Meningococcal Group B Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 171. SAMEA Meningococcal Group B Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 172. SAMEA Meningococcal Group B Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 173. SAMEA Meningococcal Group B Vaccine Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 174. SAMEA Meningococcal Group B Vaccine Sales by Country (2021-2026) & (k units) Table 175. SAMEA Meningococcal Group B Vaccine Sales by Country (2027-2032) & (k units) Table 176. SAMEA Meningococcal Group B Vaccine Sales Price by Country (2021-2026) & (US$/unit) Table 177. SAMEA Meningococcal Group B Vaccine Sales Price by Country (2027-2032) & (US$/unit) Table 178. Brazil Meningococcal Group B Vaccine Revenue (2021-2032) & (US$ Million) Table 179. Argentina Meningococcal Group B Vaccine Revenue (2021-2032) & (US$ Million) Table 180. Chile Meningococcal Group B Vaccine Revenue (2021-2032) & (US$ Million) Table 181. Colombia Meningococcal Group B Vaccine Revenue (2021-2032) & (US$ Million) Table 182. Peru Meningococcal Group B Vaccine Revenue (2021-2032) & (US$ Million) Table 183. Saudi Arabia Meningococcal Group B Vaccine Revenue (2021-2032) & (US$ Million) Table 184. Israel Meningococcal Group B Vaccine Revenue (2021-2032) & (US$ Million) Table 185. UAE Meningococcal Group B Vaccine Revenue (2021-2032) & (US$ Million) Table 186. Turkey Meningococcal Group B Vaccine Revenue (2021-2032) & (US$ Million) Table 187. Iran Meningococcal Group B Vaccine Revenue (2021-2032) & (US$ Million) Table 188. Egypt Meningococcal Group B Vaccine Revenue (2021-2032) & (US$ Million) Table 189. Key Raw Materials Table 190. Raw Materials Key Suppliers Table 191. Meningococcal Group B Vaccine Distributors List Table 192. Meningococcal Group B Vaccine Customers List Table 193. Research Programs/Design for This Report Table 194. Authors List of This Report Table 195. Secondary Sources Table 196. Primary Sources List of Figures Figure 1. Meningococcal Group B Vaccine Image Figure 2. Global Meningococcal Group B Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Meningococcal Group B Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 4. Bexsero Image Figure 5. Trumenba Image Figure 6. Other Image Figure 7. Global Meningococcal Group B Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Meningococcal Group B Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 9. Public Image Figure 10. Private Image Figure 11. Global Meningococcal Group B Vaccine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Meningococcal Group B Vaccine Revenue (2021-2032) & (US$ Million) Figure 13. Global Meningococcal Group B Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Meningococcal Group B Vaccine Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Meningococcal Group B Vaccine Revenue Market Share by Region (2021-2032) Figure 16. Global Meningococcal Group B Vaccine Sales (2021-2032) & (k units) Figure 17. Global Meningococcal Group B Vaccine Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 18. Global Meningococcal Group B Vaccine Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Meningococcal Group B Vaccine Sales YoY (2021-2032) & (k units) Figure 20. Europe Meningococcal Group B Vaccine Sales YoY (2021-2032) & (k units) Figure 21. China Meningococcal Group B Vaccine Sales YoY (2021-2032) & (k units) Figure 22. Asia (Excluding China) Meningococcal Group B Vaccine Sales YoY (2021-2032) & (k units) Figure 23. South America, Middle East and Africa Meningococcal Group B Vaccine Sales YoY (2021-2032) & (k units) Figure 24. Global Meningococcal Group B Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Meningococcal Group B Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Meningococcal Group B Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Meningococcal Group B Vaccine Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Meningococcal Group B Vaccine Revenue Market Share by Type (2021-2032) Figure 30. Global Meningococcal Group B Vaccine Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 31. Global Meningococcal Group B Vaccine Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Meningococcal Group B Vaccine Sales Market Share by Type (2021-2032) Figure 33. Global Meningococcal Group B Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Meningococcal Group B Vaccine Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Meningococcal Group B Vaccine Revenue Market Share by Application (2021-2032) Figure 36. Global Meningococcal Group B Vaccine Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 37. Global Meningococcal Group B Vaccine Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Meningococcal Group B Vaccine Sales Market Share by Application (2021-2032) Figure 39. North America Meningococcal Group B Vaccine Revenue Share by Type (2021-2032) Figure 40. North America Meningococcal Group B Vaccine Sales Share by Type (2021-2032) Figure 41. North America Meningococcal Group B Vaccine Revenue Share by Application (2021-2032) Figure 42. North America Meningococcal Group B Vaccine Sales Share by Application (2021-2032) Figure 43. North America Meningococcal Group B Vaccine Revenue Share by Country (2021-2032) Figure 44. North America Meningococcal Group B Vaccine Sales Share by Country (2021-2032) Figure 45. Europe Meningococcal Group B Vaccine Revenue Share by Type (2021-2032) Figure 46. Europe Meningococcal Group B Vaccine Sales Share by Type (2021-2032) Figure 47. Europe Meningococcal Group B Vaccine Revenue Share by Application (2021-2032) Figure 48. Europe Meningococcal Group B Vaccine Sales Share by Application (2021-2032) Figure 49. Europe Meningococcal Group B Vaccine Revenue Share by Country (2021-2032) Figure 50. Europe Meningococcal Group B Vaccine Sales Share by Country (2021-2032) Figure 51. China Meningococcal Group B Vaccine Revenue Share by Type (2021-2032) Figure 52. China Meningococcal Group B Vaccine Sales Share by Type (2021-2032) Figure 53. China Meningococcal Group B Vaccine Revenue Share by Application (2021-2032) Figure 54. China Meningococcal Group B Vaccine Sales Share by Application (2021-2032) Figure 55. Asia Meningococcal Group B Vaccine Revenue Share by Type (2021-2032) Figure 56. Asia Meningococcal Group B Vaccine Sales Share by Type (2021-2032) Figure 57. Asia Meningococcal Group B Vaccine Revenue Share by Application (2021-2032) Figure 58. Asia Meningococcal Group B Vaccine Sales Share by Application (2021-2032) Figure 59. Asia Meningococcal Group B Vaccine Revenue Share by Country (2021-2032) Figure 60. Asia Meningococcal Group B Vaccine Sales Share by Country (2021-2032) Figure 61. SAMEA Meningococcal Group B Vaccine Revenue Share by Type (2021-2032) Figure 62. SAMEA Meningococcal Group B Vaccine Sales Share by Type (2021-2032) Figure 63. SAMEA Meningococcal Group B Vaccine Revenue Share by Application (2021-2032) Figure 64. SAMEA Meningococcal Group B Vaccine Sales Share by Application (2021-2032) Figure 65. SAMEA Meningococcal Group B Vaccine Revenue Share by Country (2021-2032) Figure 66. SAMEA Meningococcal Group B Vaccine Sales Share by Country (2021-2032) Figure 67. Meningococcal Group B Vaccine Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Meningococcal Group B Vaccine Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Bexsero
  • Trumenba
  • Other
Applications
  • Public
  • Private
Companies covered
  • GSK
  • Pfizer

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Meningococcal Group B Vaccine Market by Type
  3. 1.2.1 Global Meningococcal Group B Vaccine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Bexsero
  5. 1.2.3 Trumenba
  6. 1.2.4 Other
  7. 1.3 Meningococcal Group B Vaccine Market by Application
  8. 1.3.1 Global Meningococcal Group B Vaccine Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Public
  10. 1.3.3 Private
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Meningococcal Group B Vaccine Market Dynamics
  1. 2.1 Meningococcal Group B Vaccine Industry Trends
  2. 2.2 Meningococcal Group B Vaccine Industry Drivers
  3. 2.3 Meningococcal Group B Vaccine Industry Opportunities and Challenges
  4. 2.4 Meningococcal Group B Vaccine Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Meningococcal Group B Vaccine Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Meningococcal Group B Vaccine Revenue by Region
  3. 3.2.1 Global Meningococcal Group B Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Meningococcal Group B Vaccine Revenue by Region (2021-2026)
  5. 3.2.3 Global Meningococcal Group B Vaccine Revenue by Region (2027-2032)
  6. 3.2.4 Global Meningococcal Group B Vaccine Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Meningococcal Group B Vaccine Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Meningococcal Group B Vaccine Sales by Region
  9. 3.4.1 Global Meningococcal Group B Vaccine Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Meningococcal Group B Vaccine Sales by Region (2021-2026)
  11. 3.4.3 Global Meningococcal Group B Vaccine Sales by Region (2027-2032)
  12. 3.4.4 Global Meningococcal Group B Vaccine Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Meningococcal Group B Vaccine Revenue by Manufacturers
  2. 4.1.1 Global Meningococcal Group B Vaccine Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Meningococcal Group B Vaccine Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Meningococcal Group B Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Meningococcal Group B Vaccine Sales by Manufacturers
  6. 4.2.1 Global Meningococcal Group B Vaccine Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Meningococcal Group B Vaccine Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Meningococcal Group B Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Meningococcal Group B Vaccine Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Meningococcal Group B Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Meningococcal Group B Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Meningococcal Group B Vaccine Manufacturers, Product Type & Application
  13. 4.7 Global Meningococcal Group B Vaccine Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Meningococcal Group B Vaccine Market CR5 and HHI
  16. 4.8.2 2025 Meningococcal Group B Vaccine Tier 1, Tier 2, and Tier 3
5 Meningococcal Group B Vaccine Market by Type
  1. 5.1 Global Meningococcal Group B Vaccine Revenue by Type
  2. 5.1.1 Global Meningococcal Group B Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Meningococcal Group B Vaccine Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Meningococcal Group B Vaccine Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Meningococcal Group B Vaccine Sales by Type
  6. 5.2.1 Global Meningococcal Group B Vaccine Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Meningococcal Group B Vaccine Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Meningococcal Group B Vaccine Sales Market Share by Type (2021-2032)
  9. 5.3 Global Meningococcal Group B Vaccine Price by Type
6 Meningococcal Group B Vaccine Market by Application
  1. 6.1 Global Meningococcal Group B Vaccine Revenue by Application
  2. 6.1.1 Global Meningococcal Group B Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Meningococcal Group B Vaccine Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Meningococcal Group B Vaccine Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Meningococcal Group B Vaccine Sales by Application
  6. 6.2.1 Global Meningococcal Group B Vaccine Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Meningococcal Group B Vaccine Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Meningococcal Group B Vaccine Sales Market Share by Application (2021-2032)
  9. 6.3 Global Meningococcal Group B Vaccine Price by Application
7 Company Profiles
  1. 7.1 GSK
  2. 7.1.1 GSK Company Information
  3. 7.1.2 GSK Business Overview
  4. 7.1.3 GSK Meningococcal Group B Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 GSK Meningococcal Group B Vaccine Product Portfolio
  6. 7.1.5 GSK Recent Developments
  7. 7.2 Pfizer
  8. 7.2.1 Pfizer Company Information
  9. 7.2.2 Pfizer Business Overview
  10. 7.2.3 Pfizer Meningococcal Group B Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Pfizer Meningococcal Group B Vaccine Product Portfolio
  12. 7.2.5 Pfizer Recent Developments
8 North America
  1. 8.1 North America Meningococcal Group B Vaccine Market Size by Type
  2. 8.1.1 North America Meningococcal Group B Vaccine Revenue by Type (2021-2032)
  3. 8.1.2 North America Meningococcal Group B Vaccine Sales by Type (2021-2032)
  4. 8.1.3 North America Meningococcal Group B Vaccine Price by Type (2021-2032)
  5. 8.2 North America Meningococcal Group B Vaccine Market Size by Application
  6. 8.2.1 North America Meningococcal Group B Vaccine Revenue by Application (2021-2032)
  7. 8.2.2 North America Meningococcal Group B Vaccine Sales by Application (2021-2032)
  8. 8.2.3 North America Meningococcal Group B Vaccine Price by Application (2021-2032)
  9. 8.3 North America Meningococcal Group B Vaccine Market Size by Country
  10. 8.3.1 North America Meningococcal Group B Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Meningococcal Group B Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Meningococcal Group B Vaccine Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Meningococcal Group B Vaccine Market Size by Type
  2. 9.1.1 Europe Meningococcal Group B Vaccine Revenue by Type (2021-2032)
  3. 9.1.2 Europe Meningococcal Group B Vaccine Sales by Type (2021-2032)
  4. 9.1.3 Europe Meningococcal Group B Vaccine Price by Type (2021-2032)
  5. 9.2 Europe Meningococcal Group B Vaccine Market Size by Application
  6. 9.2.1 Europe Meningococcal Group B Vaccine Revenue by Application (2021-2032)
  7. 9.2.2 Europe Meningococcal Group B Vaccine Sales by Application (2021-2032)
  8. 9.2.3 Europe Meningococcal Group B Vaccine Price by Application (2021-2032)
  9. 9.3 Europe Meningococcal Group B Vaccine Market Size by Country
  10. 9.3.1 Europe Meningococcal Group B Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Meningococcal Group B Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Meningococcal Group B Vaccine Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Meningococcal Group B Vaccine Market Size by Type
  2. 10.1.1 China Meningococcal Group B Vaccine Revenue by Type (2021-2032)
  3. 10.1.2 China Meningococcal Group B Vaccine Sales by Type (2021-2032)
  4. 10.1.3 China Meningococcal Group B Vaccine Price by Type (2021-2032)
  5. 10.2 China Meningococcal Group B Vaccine Market Size by Application
  6. 10.2.1 China Meningococcal Group B Vaccine Revenue by Application (2021-2032)
  7. 10.2.2 China Meningococcal Group B Vaccine Sales by Application (2021-2032)
  8. 10.2.3 China Meningococcal Group B Vaccine Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Meningococcal Group B Vaccine Market Size by Type
  2. 11.1.1 Asia Meningococcal Group B Vaccine Revenue by Type (2021-2032)
  3. 11.1.2 Asia Meningococcal Group B Vaccine Sales by Type (2021-2032)
  4. 11.1.3 Asia Meningococcal Group B Vaccine Price by Type (2021-2032)
  5. 11.2 Asia Meningococcal Group B Vaccine Market Size by Application
  6. 11.2.1 Asia Meningococcal Group B Vaccine Revenue by Application (2021-2032)
  7. 11.2.2 Asia Meningococcal Group B Vaccine Sales by Application (2021-2032)
  8. 11.2.3 Asia Meningococcal Group B Vaccine Price by Application (2021-2032)
  9. 11.3 Asia Meningococcal Group B Vaccine Market Size by Country
  10. 11.3.1 Asia Meningococcal Group B Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Meningococcal Group B Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Meningococcal Group B Vaccine Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Meningococcal Group B Vaccine Market Size by Type
  2. 12.1.1 SAMEA Meningococcal Group B Vaccine Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Meningococcal Group B Vaccine Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Meningococcal Group B Vaccine Price by Type (2021-2032)
  5. 12.2 SAMEA Meningococcal Group B Vaccine Market Size by Application
  6. 12.2.1 SAMEA Meningococcal Group B Vaccine Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Meningococcal Group B Vaccine Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Meningococcal Group B Vaccine Price by Application (2021-2032)
  9. 12.3 SAMEA Meningococcal Group B Vaccine Market Size by Country
  10. 12.3.1 SAMEA Meningococcal Group B Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Meningococcal Group B Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Meningococcal Group B Vaccine Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Meningococcal Group B Vaccine Value Chain Analysis
  2. 13.1.1 Meningococcal Group B Vaccine Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Meningococcal Group B Vaccine Production Mode & Process
  6. 13.2 Meningococcal Group B Vaccine Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Meningococcal Group B Vaccine Distributors
  9. 13.2.3 Meningococcal Group B Vaccine Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst